Evidence map›Paper›PMID 31913578›Full record

ArticleJournal of clinical hypertension (Greenwich, Conn.)2020

Hypertension prevalence and control in Ulaanbaatar, Mongolia.

Harry Potts, Uurtsaikh Baatarsuren, Maral Myanganbayar, Baigal Purevdorj, Burtu-Ujin Lkhagvadorj, Namuun Ganbat, Alimaa Dorjpalam, Delgerbat Boldbaatar, Khulan Tuvdendarjaa, Dulmaa Sampilnorov and 12 more

Abstract read
In one paragraph

Article in Journal of clinical hypertension (Greenwich, Conn.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Hypertension prevalence and control in Ulaanbaatar, Mongolia.Journal of clinical hypertension (Greenwich, Conn.) · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Harry PottsSchool of Clinical Medicine, University of Cambridge, Cambridge, UK.ORCID 0000-0002-3098-0527
Uurtsaikh BaatarsurenOnom Foundation, Ulaanbaatar, Mongolia.ORCID 0000-0001-5286-8790
Maral MyanganbayarOnom Foundation, Ulaanbaatar, Mongolia.ORCID 0000-0003-0971-3405
Baigal PurevdorjOnom Foundation, Ulaanbaatar, Mongolia.ORCID 0000-0002-1510-0229
Burtu-Ujin LkhagvadorjOnom Foundation, Ulaanbaatar, Mongolia.ORCID 0000-0001-6813-9947
Namuun GanbatOnom Foundation, Ulaanbaatar, Mongolia.ORCID 0000-0002-3557-8481
Alimaa DorjpalamOnom Foundation, Ulaanbaatar, Mongolia.ORCID 0000-0003-4768-0069
Delgerbat BoldbaatarOnom Foundation, Ulaanbaatar, Mongolia.ORCID 0000-0001-8095-0345
Khulan TuvdendarjaaOnom Foundation, Ulaanbaatar, Mongolia.ORCID 0000-0002-4845-4840
Dulmaa SampilnorovOnom Foundation, Ulaanbaatar, Mongolia.ORCID 0000-0002-1636-4007
Khatantuul BoldbaatarOnom Foundation, Ulaanbaatar, Mongolia.ORCID 0000-0003-2815-8523
Myagmartseren DashtserenMongolian Society of Hypertension, Ulaanbaatar, Mongolia.ORCID 0000-0002-7315-2908
Batbold BatsukhMongolian Society of Hypertension, Ulaanbaatar, Mongolia.ORCID 0000-0002-5432-6191
Namkhaidorj TserengomboMongolian Society of Hypertension, Ulaanbaatar, Mongolia.ORCID 0000-0001-6860-2938
Tsolmon UnurjargalMongolian Society of Hypertension, Ulaanbaatar, Mongolia.ORCID 0000-0002-6682-0023
Enkhtuya PalamNational Center for Public Health, Ulaanbaatar, Mongolia.ORCID 0000-0002-1941-7813
Roberta BosurgiNovartis Foundation, Basel, Switzerland.
Geoffrey SoNovartis Foundation, Basel, Switzerland.
Norm R C CampbellLibin Cardiovascular Institute of Alberta, Calgary, AB, Canada.ORCID 0000-0002-1093-4742
Andreas BungertOnom Foundation, Ulaanbaatar, Mongolia.ORCID 0000-0003-1515-7759
Naranbaatar DashdorjOnom Foundation, Ulaanbaatar, Mongolia.ORCID 0000-0003-2530-2200
Naranjargal DashdorjOnom Foundation, Ulaanbaatar, Mongolia.ORCID 0000-0003-3826-117X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study examines the prevalence, awareness, treatment, and control of hypertension in Ulaanbaatar, Mongolia, using both the American Heart Association and conventional thresholds (130/80 and 140/90 mm Hg, respectively). In this randomized cross-sectional study, two-stage cluster sampling was used to obtain a sample of 4515 individuals aged ≥20 years. Hypertension was defined by the use of antihypertensives in the last 2 weeks or a blood pressure at or above the thresholds of 140/90 and 130/80 mm Hg. The mean age of the participants was 41.1 ± 14.0 years and 54.5% were women. Hypertension prevalence was 25.6% (using 140/90 mm Hg) and 46.5% (using 130/80 mm Hg). Prevalence increased with age and below 50 years men were consistently more likely to be hypertensive. Among hypertensive participants, the rates of awareness, treatment, and control were 69.7%, 46.8%, and 24.0% (using 140/90 mm Hg) and 49.1%, 25.8%, and 6.4% (using 130/80 mm Hg, respectively). Men had lower rates of awareness, treatment, and control compared with women, with the most pronounced differences at younger ages. This study shows that awareness, treatment, and control rates in Ulaanbaatar are better than in most low- and middle-income countries but are still suboptimal. The largest "care gap" was in young men where a regulatory requirement for annual workplace blood pressure screening has the potential to enhance care. A major hypertension control program has just been initiated in Ulaanbaatar.

Indexed as

HypertensionAdultAgedAntihypertensive AgentsAwarenessBlood PressureCross-Sectional StudiesFemaleHealth Knowledge, Attitudes, PracticeHumansMaleMiddle AgedMongoliaPrevalenceAntihypertensive Agentshypertension awarenesshypertension controlhypertension prevalencehypertension treatment

Identifiers

PMID31913578
PMCPMC8029771

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.